Characterizing the human T-cell receptor repertoire by massively parallel sequencing
Characterizing the human T-cell receptor repertoire by massively parallel sequencing
批准号:
190756
负责人:
Holt Rob
金额:
$65.8万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2009
资助国家:
加拿大
项目状态:
已结题
起止时间:
2009-09-01 至 2013-09-01
中文摘要
血液中循环的T细胞是适应性免疫系统的关键参与者,在识别和杀死其他感染病毒或携带致癌突变的细胞方面尤为重要。 因为有大量的
英文摘要
T-cells circulating in blood are the key players in your adaptive immune system and are particularly important in recognizing and killing other cells that are infected with viruses, or that carry cancer causing mutations. Because there are a vast number
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Lentiviral infusion as a universal approach for genetically modified immune effector cell therapies.
-
批准号:435855
-
项目类别:Operating Grants
-
资助金额:$46.81万
-
财政年份:2020
-
负责人:Holt Rob
-
依托单位:
Engineering T cells to overcome an immunosuppressive solid tumour microenvironment
-
批准号:369095
-
项目类别:Operating Grants
-
资助金额:$10.93万
-
财政年份:2017
-
负责人:Holt Rob
-
依托单位:
Immunogenicity and HLA restriction of kinase mutations in colorectal adenoma and carcinoma patients
-
批准号:183532
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2009
-
负责人:Holt Rob
-
依托单位:
Linking Infectious Agents to Cancer: A Metagenomics Approach
-
批准号:172981
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2008
-
负责人:Holt Rob
-
依托单位:
海外基金